Catalyst Wire Dossier Catalyst Wire Dossier

Electrical transcutaneous auricular vagal stimulation (taVNS)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Electrical transcutaneous auricular vagal stimulation (taVNS), covering 2025-04-30 to 2025-04-30. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Outcome of Electrical Transcutaneous Auricular Vagal Stimulation in Patients With Stable Symptomatic Chronic Heart Failure [NA]

See pricing